MedImmune

Seattle Genetics to Present at Upcoming Investor Conferences

redorbit.com     Aug 27, 2008   1 related          

Posted on: Wednesday, 27 August 2008, 09:01 CDT Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer of Seattle Genetics, will present at two upcoming...                    

comments

Federal Circuit Finds Jurisdiction Lacking in Declaratory Judgment Action Seeking to Avoid Patent...

federalcivilpracticebulletin.blogspot.com     Aug 26, 2008          

Per U.S. Law Week, Volume 77, Number 8, Tuesday, August 26, 2008:A company's desire to determine whether its product infringed patents held by a competitor did not create a case or controversy sufficient to support the...                    

comments

                   

NEA Expands Healthcare Investing Practice With Appointment of Ed Mathers as Partner

prnewswire.com     Aug 26, 2008          

NEA Expands Healthcare Investing Practice With Appointment of Ed Mathers as Partner CHEVY CHASE, Md. Aug. 26 /PRNewswire/ -- New Enterprise Associates, Inc. (NEA), a leading global venture capital firm, today announced...                    

comments

BioSpectrum Top 20: Sun Pharmaceuticals (6)

pharmiweb.co.uk     Aug 26, 2008          

Listing Year: 1994 (Start-up Year: 1983) Business: Manufactures and markets a large basket of pharmaceutical formulations as branded generics, as well as generics Address: 17/B, Mahal Industrial Estate, Mahakali Caves...                    

comments

                   

Biota RSV licence assigned to AZ - territories expanded

pharmiweb.co.uk     Aug 26, 2008          

Melbourne, Australia and Alderly Park, United Kingdom - 26 August 2008 ... Biota Holdings Limited (ASX:BTA) and AstraZeneca (NYSE:AZN) today announced that the 2005 Collaboration and License Agreement with MedImmune has...                    

comments

                   

Kellogg School Corner | Guide to a good marketing plan

livemint.com     Aug 24, 2008          

It is the product of untold hours of labour, hailed as the key to a company’s success—and it is frequently left abandoned on a bookshelf, for the most part unread. It is the marketing plan: too often, wordy, unfocused,...                    

comments

Parents don't consider flu shot

upi.com     Aug 22, 2008   11 related          

ROCHESTER, N.Y., Aug. 22 (UPI) -- Parents of U.S. teens say vaccination ranks next to last among things they can do to help protect their children against influenza, a survey indicates. Although U.S. public health officials say...                    

comments

                   

Pharmaceutical Alliance Management

pharmiweb.co.uk     Aug 22, 2008   3 related          

DUBLIN, Ireland-- --Research and Markets has announced the addition of the "Pharmaceutical Alliance Management" report to their offering. Drive revenue through alliance success: Nearly half of today’s top-selling drugs...                    

comments

                   

MedImmune initiates phase 2a trial of lupus drug MEDI-545

pharmiweb.co.uk     Aug 20, 2008          

Princeton, New Jersey Medarex, Inc announced that its partner MedImmune, Inc has initiated a phase-2A multi-dose clinical trial of MEDI-545 for the potential treatment of systemic lupus erythematosus (SLE or lupus). MEDI-545 is...                    

comments

AstraZeneca Gives FluMist Spray a Shot in the Arm (at Seeking Alpha)

yahoo.com     Aug 19, 2008   5 related          

by: Mike Huckman posted on: August 19, 2008 | about stocks: Ads for flu vaccines have traditionally been confined to public service announcements (PSAs), health and media alerts. So, that's why I was surprised to see this...                    

comments

1 2 3 4 5 next »